G. V. Karakashev

G. V. Karakashev

Auto-generated profile, based on publicly available information

G. V. Karakashev

Research Institute of Hygiene, Occupational Pathology and Human Ecology

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Аналитика и контроль
Verified
Journal Article
Closed access
ESE. I. Savel`eva
E. I. Savel`eva
MLMikhail Leninskii
Mikhail Leninskii
IVIrina Vasileva
Irina Vasileva
GKG. V. Karakashev
G. V. Karakashev
NSN. A. Samchenko
N. A. Samchenko
To date, chemical weapons in the Russian Federation have been completely destroyed. Former chemical weapons destruction facilities (CWDFs) are subject to re-profiling. The most important stage of this activity is to assess the safety of engineering elements of the facilities to find out whether they can be involved in national economy. The most toxic and persistent substance processed at the CWDFs was a V-series agent. The certified gas chromatographic methods previously used for control of residual amounts of this substance on the surfaces and in deep layers of materials were based on its conversion to acid fluoride on silver fluoride pads. The latter are no longer produced, and these methods are impossible to use. The use of liquid tandem chromatography-mass spectrometry (HPLC-MS/MS) provided a direct determination of VR in the different matrices at the level of the toxicity threshold. At the same time HPLC-MS/MS method allows to determine the toxic acid formed by the hydrolysis of the P–O bond in the VR molecule. Previously no methods for the determination of this acid were available. A unified procedure for the sensitive target determination of VR (O-isobutyl S- (2-diethylamino)ethyl methylphosphonothioate) and its most toxic hydrolysis product S-[(2-diethylamino)ethyl] methylphosphonothioic acid in surface wipes and in deep layers of various materials is proposed. The method involves the addition of an internal standard (paraoxon) to the sample, extraction with methanol, concentration of the extract, and analysis by HPLC-MS/MS in the multiple reaction monitoring (MRM) mode. The detection limits of the analytes are close to their toxic threshold levels. Special emphasis in the procedure is paid to the reliability of identification of the analytes, which is of key importance in international investigations under the Chemical Weapons Convention.

25 February 2025 in Toxicological Review
Verified
Journal Article
Closed access
PDF file
ОООльга Игоревна Орлова
Ольга Игоревна Орлова
NKNadezhda L. Koryagina
Nadezhda L. Koryagina
ESElena I. Savelyeva
Elena I. Savelyeva
ГКГеоргий Васильевич Каракашев
Георгий Васильевич Каракашев
АУАнтон Игоревич Уколов
Антон Игоревич Уколов
АРАндрей Станиславович Радилов
Андрей Станиславович Радилов
Introduction. The presence of prohibited compounds undeclared by the manufacturer in specialized food products (dietary supplements and sports nutrition products) is a violation of TR CU 021. However, the variety of chemical classes of prohibited compounds, their high biological activity and low effective concentrations determine the need for the use of highly sensitive chromatomass spectrometric methods for their detection. The aim of the work was to improve methodological approaches to identification during HPLC-MS/MS analysis of food products for the content of prohibited substances. Material and methods. The study were carried out by HPLC with tandem mass-selective detection with ionization in electrospray in the target screening mode. Samples of dietary supplements and sports nutrition products were used as objects. Results. The probable sources of false positive results of the analysis are considered and classified, examples from real practice are given. It is indicated that the main reasons for the appearance of false positive results may be: close values of the m/z precursor ions of the compounds being determined (the difference is less than 1 unit m/z); similarity of the structure of the compounds under study; the compound under study does not form a molecular precursor ion; matrix effects; cross-contamination. Limitations. 5 main sources of identification errors associated with incorrect interpretation of mass spectra are analyzed. Conclusion. The solution of the problems of reliable identification of prohibited compounds in dietary supplements is possible through the continuous development and improvement of screening methodology, the development of new methodological approaches, evaluation of their advantages and possible limitations.

17 November 2025 in Extreme Medicine
Verified
Journal Article
Closed access
VAV. V. Abzianidze
V. V. Abzianidze
NSN. V. Skvortsov
N. V. Skvortsov
GKG. V. Karakashev
G. V. Karakashev
PBP. P. Beltyukov
P. P. Beltyukov
DSD. S. Suponina
D. S. Suponina
DKD. V. Krivorotov
D. V. Krivorotov
Introduction. The determination of metabolism and pharmacokinetics is an essential requirement in the development of any drug. Phaeosphaeride A (PPA) is an anticancer agent belonging to the group of natural compounds with antitumor properties, which was first isolated from the endophytic fungus FA39 by Harvard scientists (Claudy et al.) in 2006. In this study, we investigate compound AV6, which is a derivative of natural phaeosphaeride A. Objective. To study the acute toxicity and pharmacokinetic characteristics of the semi-synthetic substance AV6 obtained based on phaeosphaeride A, a natural phytotoxin with antitumor properties, following a single intragastric administration of AV6 in laboratory rodents. Materials and methods . The acute toxicity of AV6 was studied using 30 male Balb/c mice, which were divided into five groups of six animals each. The control group received a single intragastric administration of a solvent (oil-alcohol emulsion, 300 µL volume), while four experimental groups received AV6 at doses of 5, 50, 300, and 2000 mg/kg bw. Body weight dynamics were evaluated, and organ mass coefficients were calculated. The pharmacokinetic study was performed following a single intragastric administration of AV6 at a dose of 25 mg/kg bw to outbred male Wistar rats. The AV6 dose for the pharmacokinetic study was determined based on acute toxicity data, accounting for the interspecies conversion factor. Quantitative determination of AV6 in blood plasma and urine was performed using the MS/MS method. Statistical analysis was conducted using GraphPad Prism 5 software. Results. According to the acute toxicity data following intragastric administration, the AV6 phaeosphaeride A derivative can be classified as hazard class 3 (animal mortality was observed exclusively in the 2000 mg/kg bw group). Visual examination of internal organs revealed no apparent macroscopic signs of pathology. No statistically significant changes in the mass coefficients of internal organs were detected in experimental animals compared to controls. A quantitative determination procedure for AV6 was developed based on HPLC–MS/MS analysis. Metabolites formed in rats in vivo were identified. A comparison of rat blood plasma chromatograms 1 h and 10 h after intragastric AV6 administration showed that, after 1 h, the AV6 peak intensity was 20 times higher than the M2 peak. However, after 10 h, the AV6 peak intensity decreased, while the metabolite M2 peak intensity increased. Conclusion. Compound AV6 is classified as a moderately hazardous substance. Data on the structure of AV6 metabolites (a derivative of natural phaeosphaeride A) obtained during pharmacokinetic studies in rats indicate a relatively low metabolic rate of the compound. This is primarily due to chemical transformations at the nitrogen atom of the lactam ring, resulting in metabolites that may be excreted in urine. The most probable mechanisms of these transformations are oxidative deacylation followed by hydrolysis. The completed preclinical study evaluating the acute toxicity, metabolism, and pharmacokinetics of AV6 represents a crucial step in translating previous findings on the antitumor potential of this derivative of natural phaeosphaeride A and advancing in vivo research.